injection site reaction glp 1 Hypersensitivity to glucagon‐like peptide‐1 receptor agonists: A case of delayed urticaria‐like rash to dulaglutide and literature review - Bianchi - 2024 - JEADV Clinical Practice What to Know about GLP-1

Patients often describe fewer cravings, more stable energy throughout the day, and a greater sense of control around food

Patients who combine GLP-1 medications with regular physical activity tend to have better body composition outcomes meaning more of the weight they lose is fat rather than muscle

Availability is another factor

Three-year outcomes of post-acute sequelae of COVID-19

The glucagon component may partially offset constipation through its own gastrointestinal effects, but published data is still limited

Furthermore, preliminary data indicates GLP-1 RAs might lower the risk of developing atrial fibrillation in specific heart failure patient populations